MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease

N. Ben Ali, M. Ben Mahmoud, E. Derbel, H. Jamoussi, S. Fray, M. Fredj (Tunis, Tunisia)

Meeting: 2022 International Congress

Abstract Number: 805

Keywords: Parkinson’s

Category: Parkinson's Disease: Psychiatric Manifestations

Objective: The aim of the study was to evaluate psychiatric manifestations of Parkinson’s disease (PD) and to establish statistical links with sociodemographic and clinical PD characteristics.

Background: Parkinson’s disease (PD), originally called “paralysis agitans”, is commonly known by motor and non-motor symptoms. Among various non-motor manifestations, psychiatric disturbances still underdiagnosed despite their frequency and disabling character.

Method: We performed a prospective population-based study of patients followed in the department of Neurology of Charles Nicolle hospital of Tunisia for PD with MMSE score > 24. All patients were interviewed during regularly scheduled follow-up visits, clinical PD stage were identified (prodromal (P-PD) and clinical phases (C-PD) and psychological symptoms were assessed using Brief Psychiatric Rating Scale-Expanded (BPRS-E). Statistical analysis was performed using SPSS version 18.

Results: Thirty patients with sex ratio M/F above 0.66 were enrolled in our study with mean age of 64.17 years old. All patients had anxious symptoms (P-PD: 21.1%). Depression was found in 46.7% (P-PD: 16.1%). Psychotic signs were reported by 43.3% patients only in C-PD (Hallucinations (33.3%) and delusion (10%)). Sleep disorders (P-PD: 26.6%, C-PD: 53.4%), sexual dysfunction (C-PD:76.7%) and eating disorders (C-PD:13.3% ) were also reported. UPDRS-V score was statistically correlated with mood disorders (p=0.05). Duration of PD evolution was statistically associated with eating disorders (P=0,001). Psychiatric symptoms and patients sociodemographic characteristics, age of disease onset and L-dopa daily dose, were statistically independent.

Conclusion: Our results confirm findings reported by several authors that PD is not limited to motor system but clearly disturbs the psychiatric system. Our study analyzed meticulously the various aspects of mental disorders in different clinical stages of the PD and highlights the variability of psychiatric symptoms’ occurrence according to the clinical stage of the disease.
Given that the quality of life, and the need for institutionalization, is so highly dependent on the psychiatric well-being of patients with PD, the inter‑disciplinary approach in management of these patients should include mental health professionals.

To cite this abstract in AMA style:

N. Ben Ali, M. Ben Mahmoud, E. Derbel, H. Jamoussi, S. Fray, M. Fredj. Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/psychiatric-evaluation-according-to-brief-psychiatric-rating-scale-expanded-in-patients-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/psychiatric-evaluation-according-to-brief-psychiatric-rating-scale-expanded-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley